Skip to content
  • Researchers
  • Healthcare Professionals
  • Event Calendar
  • Contact Us
  • FR
Search
  • Facebook
  • Twitter
  • youtube
  • flickr
  • instagram
MDC logo en

Muscular Dystrophy Canada

Ignited by Passion, Fueled by Hope

MENUMENU
  • Neuromuscular Disorders (NMDs)
    • What are NMDs?
    • Signs and Symptoms
    • Types of Neuromuscular Disorders
    • NMDs and COVID-19
    • Frequently Asked Questions
    • Webinars
    • We call it a Neuromuscular Disorder
  • About Us
    • Mission, Vision and Values
    • History
    • Our Team
    • Financial Statements
    • Frequently Asked Questions
  • Services & Support
    • Systems Navigation
      • Register as a Client
      • Equipment Program
      • Community Services Fund
      • Family and Caregiver Retreats
      • Educational Resources
    • Research
      • Clinical Trials
        • About Clinical Trials
        • Before Enrolling
        • Frequently Asked Questions
      • Research News
      • Research Grants
      • Research Outcomes
      • Research Hotline
      • Driving Research Forward
    • Advocacy
      • Access to Treatments
      • Accessible Canada Act
      • Self Advocacy
      • Transition to Adulthood
      • Accessible Travel
      • Journey Mapping
      • DIAP
      • Advocacy News
    • Newborn Screening
    • Need Help?
  • Get Involved
    • Fire Fighters
      • National Fire Fighter Relations Committee
      • Fire Fighter Team
    • Join our Community
    • Participate in an Event
    • Organize an Event
    • Volunteer
    • Community Champions
    • Career Opportunities
  • Gifts & Giving
    • Monthly Donations
    • Legacy and Estate Giving
    • Leadership Gifts
    • Workplace Giving
    • Corporate Sponsorship
    • Donor Bill of Rights
  • Newsroom
    • News
    • Reports
    • Press Releases
    • Newsletters
    • Testimonials and Stories
  • Donate

Press Releases


  • Home
  • >
  • Newsroom
  • >
  • Press Releases
  • Canadian Fire Fighters, donors, like-minded partners and the neuromuscular community are driving real progress in research – breaking barriers by building hope

    Canadian Fire Fighters, donors, like-minded partners and the neuromuscular community are driving real progress in research – breaking barriers by building hope

    April 15, 2025
    FOR IMMEDIATE RELEASE – Muscular Dystrophy Canada is thrilled to advance neuromuscular research by awarding $900,000 to the recipients of the 2025 annual Neuromuscular Research Grants competition. Through this year’s competition we are excited to be supporting clinical and translational research projects focused on managing symptoms, healthcare assessments, understanding diagnosis and disease progression, enhancing care, discovering …Continue Reading
  • Muscular Dystrophy Canada Welcomes Danielle Campo McLeod as National Ambassador

    Muscular Dystrophy Canada Welcomes Danielle Campo McLeod as National Ambassador

    March 28, 2025
    March 17, 2025 – Toronto, ON – Muscular Dystrophy Canada is proud to announce the appointment of Danielle Campo McLeod as our new National Ambassador. This inaugural role is a key component of Muscular Dystrophy Canada’s strategy to expand our reach, elevate brand awareness, and increase engagement with new and existing stakeholders across Canada. Reporting …Continue Reading
  • Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

    Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

    January 27, 2025
    Toronto, Ontario, Canada, January 27, 2025 – Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy. This transformative, year-long project will offer no-cost genetic testing to those with suspected myotonic dystrophy, providing a critical pathway to earlier and more accurate diagnoses. Alongside genetic …Continue Reading
  • 100 percent of Canada is now screening infants for spinal muscular atrophy, a potentially fatal disorder

    100 percent of Canada is now screening infants for spinal muscular atrophy, a potentially fatal disorder

    August 20, 2024
      Muscular Dystrophy Canada and partners deliver on goal outlined in Canada’s Rare Disease Strategy Toronto, Ontario, Canada, August 20, 2024 – Muscular Dystrophy Canada is thrilled to announce that after three years of working with each Canadian province and territory, all babies born in Canada can now be tested for spinal muscular atrophy (SMA). This …Continue Reading
  • Moving Research & Discovery Forward – The 2024 Neuromuscular Clinical and Translational Research Grant Recipients

    Moving Research & Discovery Forward – The 2024 Neuromuscular Clinical and Translational Research Grant Recipients

    March 21, 2024
    Muscular Dystrophy Canada (MDC) is pleased to announce the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects focused on managing healthcare, understanding diagnosis and disease progression, enhancing care, discovering novel treatments and therapies and moving research towards the development of cures. This …Continue Reading
  • Donors make it possible to invest in both neuromuscular disorder research and care, now and for the future

    Donors make it possible to invest in both neuromuscular disorder research and care, now and for the future

    January 29, 2024
    FOR IMMEDIATE RELEASE – Muscular Dystrophy Canada (MDC) together with the Neuromuscular Disease Network for Canada (NMD4C) are thrilled to announce the recipients of the National Clinical and Post-doctoral Fellowships funding competition. This competition involves an extensive review by leading Canadian neuromuscular researchers and clinicians to ensure the top-ranked candidates are selected for this funding opportunity. “Too …Continue Reading
  • Important Update on Phone Solicitations

    Important Update on Phone Solicitations

    December 11, 2023
    Muscular Dystrophy Canada does not use telemarketing services. You can support Fire Fighters and help them Fill the Boot for Muscular Dystrophy Canada and the individuals and families affected by neuromuscular disorders by going to filltheboot.ca. STATEMENT REGARDING PHONE SOLICITATIONS Several years ago, the Canadian Fire Fighter Curling Association (CFFCA) retained a telemarketing company to …Continue Reading
  • Governments across Canada urged to close current gap in care for debilitating neuromuscular disease by funding treatment advancements

    Governments across Canada urged to close current gap in care for debilitating neuromuscular disease by funding treatment advancements

    December 7, 2023
    Toronto, Ontario – Access to innovative care is vital for Canadians living with myasthenia gravis (MG) to help relieve the considerable impact faced by those affected by this rare neuromuscular disorder. For the first time in over 30 years, treatment advancements for adults with refractory MG have been approved in Canada, bringing hope to those for …Continue Reading
  • Community Statement: Update on Deflazacort®/Calcort® Availability

    Community Statement: Update on Deflazacort®/Calcort® Availability

    December 1, 2023
    We want to bring your attention to recent developments surrounding the availability of Deflazacort®/Calcort®, a corticosteroid vital to many Canadians affected by Duchenne muscular dystrophy. Up until 2023, Deflazacort was accessible at a relatively low cost in Canada through Health Canada’s Special Access Program despite intermittent supply shortages. In February, due to a change in …Continue Reading
  • Quebec joins the ranks of provinces screening newborns for life-threatening disorder

    Quebec joins the ranks of provinces screening newborns for life-threatening disorder

    October 4, 2023
    FOR IMMEDIATE RELEASE – Muscular Dystrophy Canada (MDC) is thrilled to announce that spinal muscular atrophy (SMA) has been added to the newborn screening panel in Quebec. A significant milestone for the province and MDC. “Congratulations to the Government of Quebec on this step, which will lead to early diagnosis and treatments that will have …Continue Reading

Become a monthly donor

Canadians impacted by neuromuscular disorders need your help.

Donate Now

Be in the Know

Subscribe to receive e-communications from MDC

Subscribe Now

Join our Community

Receive and/or provide services and assistance

Register Now
  • Facebook
  • Twitter
  • youtube
  • flickr
  • instagram
  • Contact Us
  • Privacy Policy
  • Sitemap
Visit the Imagine Canada website
Charitable Registration # 10775 5837 RR 0001 | © 2025 Muscular Dystrophy Canada – Site credits